News
Lumonus inks joint venture with NY cancer centre to scale AI oncology
Lumonus, a GenesisCare spinout chaired by Merrick Howes, is partnering with a New York cancer centre to co-develop automated radiotherapy planning tools.
Company · Healthcare
GenesisCare
Australia's largest provider of cancer care services
Funding history
Investors
Every investor coverage indicates participated in a round GenesisCare raised.
What GenesisCare bought
Companies GenesisCare acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
People
Coverage
Stories naming GenesisCare. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
undisclosed
$28m
Investment Notes: Lumonus
Investible announces it backed Lumonus' A$28 million round with three co-investors, the first deal from its new early-stage fund; Lumonus builds AI software that automates cancer clinic workflows.
6 deals
Brandon Capital news
Index of the venture firm's portfolio updates: financing rounds for AdvanCell and ENA Respiratory, grant awards via incubator programs, two closes of Fund Six, board hires, and Myricx Bio's completed sale to Novartis.
Also Brandon BioCatalyst portfolio·Brandon Capital portfolio·Uniseed·Brandon Capital portfolio·Brandon BioCatalyst portfolio·Brandon BioCatalyst portfolio·Brandon Capital portfolio·Brandon Capital portfolio·Brandon Capital portfolio·SmartCompany·AFR Technology·Startup Daily·Startup Daily·SmartCompany·Startup Daily·Startup Daily·@AuManufacturing·finance.yahoo.com·enarespiratory.com·Mirage News·advancell.com.au·Forbes Australia·datapile.co·Dealroom·Forbes Australia·datapile.co·Biotech Dispatch·fundedstartupsdaily.com·fundedstartupsdaily.com